Swift Biosciences Unveils qPCR Primer Tech; Hopes to Market First Product by Year's End

Swift this week publicly presented the first research results for its core technology, a new kind of highly sensitive qPCR primer designed for mutation and low copy number detection, and said it would eventually market products in the research, diagnostics, and next-generation sequencing spaces.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.